Drugs Repurposing for Coronavirus Treatment: Computational Study Based On Molecular Topology
Keywords:Coronavirus, COVID-19, New drugs, drugs repurposing, molecular topology
The present communication illustrates the results of a computational study based on molecular topology, focused on the repositioning of drugs to treat the SARS-CoV-2 virus, better known as coronavirus, responsible for the COVID-19 disease. Using lopinavir, a well-known viral protease inhibitor as the reference drug, a mathematical pattern is found allowing the screening of the market drugs, searching for potential candidates to inhibit the said enzyme. This way new possible therapeutic alternatives to fight the coronavirus are found. Results indicate that antivirals such as brecanavir, as well as various groups of drugs, among which are antibiotics of the macrolide family (azithromycin, clarithromycin and erythromycin among others) could be useful in treating COVID-19 infection.
Galvez J. Molecular Topology and Drug Design Unit. Jorge Galvez Researchgate profile page. Available at: https://www.researchgate.net/profile/Jorge_Galvez2.
The Protein Data Bank archive (PDB). New Coronavirus Protease Structure Available. Available at: http://www.wwpdb.org/news/news#5e39e03fa5007a04a313edc3.
CMC-database. Comprehensive Medicinal Chemistry. Available at: http://www.akosgmbh.de/accelrys/databases/cmc-3d.htm.
DrugBank. Available at: https://www.drugbank.ca/.